BOTOX® Treatment in Pediatric Lower Limb Spasticity
Pediatrics, Muscle Spasticity, Cerebral Palsy
About this trial
This is an interventional treatment trial for Pediatrics
Eligibility Criteria
Inclusion Criteria:
- Minimum weight of 10 kg/22 lb
- Cerebral palsy with dynamic muscle contracture /spasticity of the ankle
Exclusion Criteria:
- Muscular dystrophy, myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or mitochondrial disease
- Uncontrolled epilepsy
- Botulinum Toxin therapy of any serotype for any condition within the last 6 months
- History of surgical intervention of the lower study leg or planned surgery of any limb during the study
- Previous casting of the study limb for spasticity within 6 months or with a dynamic splint within 3 months, or planned casting or dynamic splinting for spasticity of the study limb or affected upper limb during the study
Sites / Locations
- AMS Neurology
- Harrison Clinical Management
- Children's Hospital Colorado Dept. of PM&R
- Associated Neurologists of Southern CT, P.C.
- New England Center for Clinical Research
- NW FL Clinical Research Group, LLC
- Axcess Medical Research, LLC
- Pediatric Neurology, PA
- Children's Healthcare of Atlanta Children's Rehabilitation Associates
- Rehab Institute of Chicago
- The Children's Mercy Hospital & Clinics
- Washington University School of Medicine
- Clinical Research Center of New Jersey
- NYU Hospital for Joint Diseases
- Columbia University Medical Center Dept. of Rehab. & Regenerative Medicine
- OnSite Clinical Solutions, LLC
- PMG Research of Charlotte, LLC
- Rhode Island Hospital
- Vanderbilt University Medical Center
- University of Texas Southwestern Medical Center
- Baylor College of Medicine Texas Children's Hospital
- Road Runner Research
- Seattle Children's Hospital
- Marshfield Clinic
- Semmelweis Egyetem- Ortopédiai Klinika
- Debrecen University Clinical Center, Orthopedic Clinic
- Istituto IRCCS G. Gaslini
- Daegu Fatima Hospital
- National Health Insurance Service Ilsan Hospital
- Seoul National University Hospital
- Asan Medical Center
- Samsung Medical Center
- Severance Hospital, Yonsei University Health System
- Philippine Orthopedic Center
- St. Luke's Medical Center-Quezon City
- Philippine Children's Medical Center
- Uniwersytecki Dzieciecy Szpita
- Uni Centrum Kliniczne
- Centrum Rehabilitacji Krok po Kroku
- Specjal. Gabinet Neurologiczny
- INTERMED, Lublin
- CRH ŻAGIEL MED, Lublin
- Szpital Wojewódzki Nr 2
- Neuro - Dzieci I Mlodziezy Aga
- NZOZ Mazowieckie Centrum
- Childrens Republic Hospital
- Smolensk Regional Hospital- Regional Budget State Healthcare institution
- Tyumen Regional Hospital #2 - State Budget Healthcare Institution of Tyumen region
- Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University
- Srinagarind Hospital, Khon Kaen University
- Ankara Diskapi Yildrim Beyazit
- Kocaeli Üniversitesi
- Selçuk Üniversitesi
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
BOTOX® 4 U/kg
BOTOX® 8 U/kg
Normal Saline (Placebo)
Participants received intramuscular injections of BOTOX® (botulinum toxin Type A) 4 U per kg of body weight (4 U/kg) into specified muscles of the lower limb on Day 1. Participants received weekly physical therapy (PT).
Participants received intramuscular injections of BOTOX® (botulinum toxin Type A) 8 U per kg of body weight (8 U/kg) into specified muscles of the lower limb on Day 1. Participants received weekly PT.
Participants received intramuscular injections of normal saline (placebo) into specified muscles of the lower limb on Day 1. Participants received weekly PT.